Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Armuzzi

Showing results (231-240 of 320) with videos related to

Pageof 32
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 22, 2020
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE studyJesus K Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|June 30, 2023
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-term Outcomes in a Multicentre StudyTommaso L Parigi, Rosanna Cannatelli, Olga M Nardone, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
United European Gastroenterology Journal|December 1, 2020
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort studyStefano Festa, Maria L Scribano, Daniela Pugliese, et al.
Journal of Personalized Medicine|April 30, 2021
Personalized Clinical Phenotyping through Systems Medicine and Artificial IntelligenceAlfredo Cesario, Marika D'Oria, Francesco Bove, et al.
European Journal of Gastroenterology & Hepatology|June 18, 2025
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) surveyNicola Pugliese, Cristina Bezzio, Stefano Festa, et al.
Pageof 32

Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 22, 2020
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE studyJesus K Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, et al.
Therapeutic Advances in Gastroenterology|October 13, 2025
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysisMarc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trialSilvio Danese, Severine Vermeire, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 30, 2023
Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUSTLaurent Peyrin-Biroulet, Séverine Vermeire, Geert D'Haens, et al.
Journal of Crohn'S & Colitis|June 30, 2023
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-term Outcomes in a Multicentre StudyTommaso L Parigi, Rosanna Cannatelli, Olga M Nardone, et al.
Autoimmunity Reviews|April 29, 2026
Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized careGiuseppe Privitera, Mariangela Allocca, Luca Antonioli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 10, 2023
Transition care in patients with IBD: The pediatric and the adult gastroenterologist's perspective. Results from a national surveyFabiana Castiglione, Luca Scarallo, Olga Maria Nardone, et al.
United European Gastroenterology Journal|December 1, 2020
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort studyStefano Festa, Maria L Scribano, Daniela Pugliese, et al.
Journal of Personalized Medicine|April 30, 2021
Personalized Clinical Phenotyping through Systems Medicine and Artificial IntelligenceAlfredo Cesario, Marika D'Oria, Francesco Bove, et al.
European Journal of Gastroenterology & Hepatology|June 18, 2025
Attitudes of physicians managing inflammatory bowel disease toward alterations of liver function tests: an Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) surveyNicola Pugliese, Cristina Bezzio, Stefano Festa, et al.
Pageof 32